Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
24.00    -1.00 (-4.00%)
Bid:
23.00
Ask:
25.00
Spread: 2.00 (8.696%)
Market Cap: £25.92m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Derivative Claim - Update

18 Jun 2015 08:50

RNS Number : 5360Q
Elektron Technology PLC
18 June 2015
 



Elektron Technology plc 

("Elektron" or the "Company")

 

Derivative Claim - Update

 

In its 2015 Annual Report, on page 18, the Company provided an update in relation to the derivative litigation brought by a shareholder, Mr Bridge, who holds at the date of this announcement 1.83% of the Company's ordinary shares.

On 16 and 17 June 2015 Mr Bridge's application for permission to continue the intended claim against certain current directors, Keith Daley and John Wilson, and certain former directors, Noah Franklin and Simon Acland, (together "the Directors") was considered by the High Court in the Liverpool District Registry.

 

Mr Bridge represented himself at the hearing and both the Company and the Directors were represented by counsel instructed by their respective solicitors.

Permission has been refused by His Honour Judge Hodge QC with the effect that, subject to rights of appeal, the Derivative Claim will not continue.

In his judgment refusing permission, and addressing the Company's case, Judge Hodge QC was entirely satisfied that this was a clear case where the Court should refuse permission. The nature and strength of the claim, in light of the evidence of the Directors and the difficulty in establishing loss to the Company, were such that no reasonable director would support continuation of the litigation.His Lordship was satisfied that the Court should not compel the Company to continue the litigation when disinterested shareholders were not in support, and neither was the independent board.The Judge, having noted that a failure to properly and impartially consider the Company's evidence was a feature that had permeated all of Mr Bridge's submissions, accepted the Company's submission that the way Mr Bridge had conducted the litigation meant that it would not be appropriate to allow him to conduct litigation on the Company's behalf, or to require the Company to lend its name to the action.Mr Bridge has been ordered to pay all the costs of the Company and the Directors. He must make payments on account in the sums of £40,000 (in respect of the Company's costs) and £50,000 (in respect of the costs of the Directors) by close of business on 15 July 2015. Further, costs incurred after the wasted hearing on 1 October 2014 have been awarded on the indemnity basis as, by that time and with the benefit of legal representation, Mr Bridge should have seen the action as doomed for failure. His decision to continue it took the case "outside the commercial norm".

Mr Bridge did not apply for permission to appeal at the hearing, but he has 21 days from 17 June 2015 to do so. Any application for permission would need to be made to the Court of Appeal, setting out his grounds.Further updates will be provided in due course as appropriate.

 

 

For further information:

 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

Andy Weatherstone - Chief Financial Officer

Martin Reeves - Company Secretary

finnCap

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

 

 

Notes to Editors

 

Elektron conceives, designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas:

 

· Demand for ubiquitous power and data: Connectivity Solutions

· Internet of Things, cloud computing and mobile devices: enabling automation and management of a new wave of business processes: Checkit

· Growth in high precision manufacture: Nano-positioning

· Healthcare for the ageing population: Ophthalmology

· Connected customer experiences and service delivery: E-Commerce and E-Service

 

In addition, Elektron owns a portfolio of well-established products and brands which provide customer access and feedback.

 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSDRAITLIE
Date   Source Headline
16th Dec 201911:40 amRNSResignation of Director
13th Dec 20194:27 pmRNSHolding(s) in Company
11th Dec 20196:08 pmRNSHolding(s) in Company
10th Dec 20195:18 pmRNSDirector/PDMR Shareholding
10th Dec 20199:47 amRNSDirector Dealings and Related Party Transactions
9th Dec 20194:30 pmRNSHolding(s) in Company
3rd Dec 20192:48 pmRNSCompletion of Tender Offer & Total Voting Rights
26th Nov 20197:00 amRNSResult of Tender Offer
25th Nov 20192:00 pmRNSResult of General Meeting
1st Nov 20197:00 amRNSProposed Tender Offer and Notice of GM
31st Oct 20195:17 pmRNSDirector/PDMR Shareholding
31st Oct 20199:57 amRNSContract Win
28th Oct 20197:00 amRNSHolding(s) in Company
24th Oct 20197:00 amRNSTotal Voting Rights
23rd Oct 20195:06 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHalf-year Report
2nd Oct 20195:15 pmRNSChange of Name
25th Sep 20197:00 amRNSCompletion of Sale of Elektron Technology
3rd Sep 20191:14 pmRNSElektron Technology UK Limited - Disposal update
13th Aug 20194:30 pmRNSDirector/PDMR Shareholding
31st Jul 20192:05 pmRNSSecond Price Monitoring Extn
31st Jul 20192:00 pmRNSPrice Monitoring Extension
31st Jul 20197:00 amRNSSale of Elektron Technology UK Limited
30th Jul 20193:30 pmRNSResult of AGM
5th Jul 20197:00 amRNSPosting of Annual Report & Notice of AGM
19th Jun 20195:02 pmRNSHolding(s) in Company
12th Jun 20197:00 amRNSPreliminary Results
15th May 20197:00 amRNSTrading Update & Notice of Results
15th May 20197:00 amRNSAcquisition
5th Feb 20197:00 amRNSTrading and Strategic Update
18th Dec 20189:05 amRNSBoard Changes
1st Nov 20187:00 amRNSTrading Statement
10th Oct 20181:26 pmRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
28th Aug 20189:55 amRNSHolding(s) in Company
10th Aug 20189:19 amRNSHolding(s) in Company
9th Aug 20187:00 amRNSTrading Statement
24th Jul 20187:00 amRNSCenter Parcs drives up Productivity with Checkit
18th Jul 201811:20 amRNSHolding(s) in Company
20th Jun 20183:20 pmRNSResult of Annual General Meeting
20th Jun 20187:00 amRNSAGM Trading Update
12th Jun 20187:00 amRNSCapital Markets Day
31st May 20187:00 amRNSHolding(s) in Company
30th May 201811:23 amRNSReplacement: Holding(s) in Company
30th May 20189:03 amRNSHolding(s) in Company
18th May 20187:00 amRNSPosting of Annual Report and Notice of AGM
16th May 20187:00 amRNSHolding(s) in Company
10th May 20181:46 pmRNSHolding(s) in Company
3rd May 20187:00 amRNSFinal Results
20th Apr 20187:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.